![](/img/cover-not-exists.png)
1082MO 5-year characterization of complete responses in patients with advanced melanoma who received nivolumab plus ipilimumab (NIVO+IPI) or NIVO alone
Robert, C., Long, G.V., Larkin, J., Wolchok, J.D., Hassel, J.C., Schadendorf, D., Hodi, F.S., Lebbé, C., Grob, J-J., Grossmann, K., Wagstaff, J., Chesney, J., Butler, M.O., Bechter, O., Márquez-RodaVolume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.1206
Date:
September, 2020
File:
PDF, 107 KB
2020